Alopecia Totalis Universalis Treatment UVA and Corticosteroids
M Yamashita, R Tsuboi, K Takamori
Study Information and Results:
Alopecia totalis and universalis patients 15 years old or older, who visited Juntendo University Hospital from 1994 to 1998, were enrolled in this study.
Alopecia Totalis patients (108 cases) and Alopecia Universalis patients (175 cases) were treated with one of four different regimens for more than six months, and the rate of efficacy, recurrence and adverse effects of each modality were compared.
Group 1 (N=58) was treated with topical immunotherapy using SADBE; group 2 (N=85), with topical corticosteroids; group 3 (N=104), with systemic and topical corticosteroids; group 4 (N=36), with oral 8-methoxypsoralen and general UVA irradiation combined with systemic and topical corticosteroids. The therapeutic effects were quantitatively compared by scoring the degree of hair regrowth.
The results indicated the following percentage figures for moderate and marked improvement in each group: group 1, 41.4% (15.5%); group 2, 37.6% (23.5%); group 3, 57.7% (43.3%); group 4, 72.2% (61.1%). Meanwhile, the recurrence rate was 66.6% for group 1, 30.0% for group 2, 35.6% for group 3 and 13.6% for group 4.
The efficacy rate of groups 3 and 4 was superior to that of groups 1 and 2.
Group 1 showed a low rate of marked improvement and a high recurrence rate, while group 4 showed a high rate of marked improvement and a low recurrence rate. Adverse effects caused by the application of topical and systemic corticosteroids were frequently observed in groups 2 to 4, but were improved after tapering the dose of corticosteroids.